Photobiomodulation (low-level laser therapy) for temporomandibular disorders: clinical efficacy, methodological quality, and dosimetric reporting — an umbrella review of systematic reviews and meta-analyses
Background To synthesise, at the level of systematic reviews (SRs) and meta-analyses (MAs), the efficacy of photobiomodulation (PBM)/low-level laser therapy (LLLT) for temporomandibular disorders (TMD), and to appraise the corpus’s methodological quality (AMSTAR-2), primary-study overlap, and dosimetry reporting. Methods Umbrella review of SRs/MAs of PBM/LLLT for TMD (PROSPERO: CRD420261458816). Five databases (Epistemonikos, PubMed/MEDLINE, Lens.org, LILACS, SciELO) were searched from inception to 25 July 2026 without language restriction. Quality was appraised with AMSTAR-2, overlap via corrected covered area (CCA), and dosimetry against a checklist; synthesis was narrative, and certainty was rated with GRADE using the estimates reported by the source meta-analyses. Results Of 231 records, 136 were unique and 32 SRs/MAs met inclusion. Most pooled estimates favoured PBM for short-term pain and maximum mouth opening (MMO; e.g., pain SMD − 0.55, 95% CI − 0.82 to − 0.27, Hanna 2021; MMO MD + 2.78 mm, 1.12 to 4.44, Máximo 2022), but magnitude was highly heterogeneous (I² up to 99%) and metrics non-comparable. Of 30 appraisable, 21 were AMSTAR-2 “Critically Low”, 1 “High”; just 11/32 reported a registered protocol. Across 30 reviews with retrievable study lists, 180 primary trials underpinned the corpus (45% included in ≥ 2 reviews); overall overlap was slight (CCA 5.48%). Wavelength and schedule were reported by 94%, but power density/irradiance (41%) and energy/dose (44%) in fewer than half. Conclusions PBM/LLLT may reduce temporomandibular pain (low certainty, GRADE), but the evidence is very uncertain about the effect on short-term mouth opening (very low certainty), and harms were not assessed. The review-level evidence is numerous but shows only slight primary-study overlap, is mostly of critically low methodological quality, and is inconsistent in reporting delivered-dose parameters. Pre-registered trials that report complete dosimetry would allow future syntheses to estimate the effect and its dose dependence more reliably. Registration PROSPERO CRD420261458816.
Authors
- Kapil Hazarika (ORCID: https://orcid.org/0000-0002-1177-4576)
- Kadambari Bharali (ORCID: https://orcid.org/0000-0001-9963-3606)
- Nilutpal Deuri (ORCID: https://orcid.org/0009-0003-8045-2989)
Institutions
- Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital (IN)
Publication Details
- Journal
- BMC Oral Health
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1186/s12903-026-10479-z
- Primary Topic
- Laser Applications in Dentistry and Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00